Oncolytics Biotech (ONCY)
0.51
+0.01 (2.00%)
Upcoming Events
Latest Headlines
Form 8-K ONCOLYTICS BIOTECH INC For: Oct 20
October 20, 2026 9:38 AM - SEC Filing
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
October 20, 2026 9:35 AM - Globe NewsWire
Form 8-K ONCOLYTICS BIOTECH INC For: Oct 14
October 14, 2026 9:33 AM - SEC Filing
Oncolytics updates GOBLET study timeline, expects PanCAN grant payment
October 14, 2026 9:30 AM - StreetInsider
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
October 14, 2026 9:30 AM - Globe NewsWire
Form 8-K ONCOLYTICS BIOTECH INC For: Oct 12
October 13, 2026 8:11 AM - SEC Filing
Oncolytics Biotech updates patent portfolio for pelareorep
October 12, 2026 4:06 PM - StreetInsider
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
October 12, 2026 4:05 PM - Globe NewsWire
Form DEFA14A ONCOLYTICS BIOTECH INC
October 6, 2026 4:29 PM - SEC Filing
Form DEF 14A ONCOLYTICS BIOTECH INC For: Dec 31
October 6, 2026 4:28 PM - SEC Filing
Form 8-K ONCOLYTICS BIOTECH INC For: Sep 29
September 29, 2026 9:35 AM - SEC Filing
Oncolytics publishes pelareorep liver cancer immune response data
September 29, 2026 9:30 AM - StreetInsider
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
September 29, 2026 9:30 AM - Globe NewsWire
Form 8-K ONCOLYTICS BIOTECH INC For: Sep 28
September 28, 2026 9:32 AM - SEC Filing
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
September 28, 2026 9:30 AM - Globe NewsWire
Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
September 11, 2026 8:45 AM - StreetInsider
Form 8-K ONCOLYTICS BIOTECH INC For: Sep 10
September 10, 2026 8:18 AM - SEC Filing
Oncolytics reports preclinical data on pelareorep with RAS inhibitor
September 10, 2026 8:15 AM - StreetInsider
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
September 10, 2026 8:15 AM - Globe NewsWire
Oncolytics Biotech (ONCY) PT Lowered to $5 at H.C. Wainwright
August 19, 2026 6:43 AM - StreetInsider
Form 8-K ONCOLYTICS BIOTECH INC For: Aug 18
August 18, 2026 9:03 AM - SEC Filing
Oncolytics gets FDA feedback on colorectal cancer trial expansion
August 18, 2026 9:01 AM - StreetInsider
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
August 18, 2026 9:00 AM - Globe NewsWire
Form 10-Q ONCOLYTICS BIOTECH INC For: Jun 30
August 12, 2026 4:19 PM - SEC Filing
Form 8-K ONCOLYTICS BIOTECH INC For: Jul 20
July 24, 2026 4:40 PM - SEC Filing
Full Article List
